查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1771482

DNA製造市场规模、份额、趋势分析报告：按类型、等级、应用、最终用途、地区、细分市场预测，2025-2030年

DNA Manufacturing Market Size, Share & Trends Analysis Report By Type, By Grade, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

DNA製造市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球DNA製造市场规模预计到2030年将达到149.6亿美元，2025年至2030年期间的复合年增长率为18.10%。

随着合成生物学应用、个人化治疗和先进疫苗开发需求的不断增长，DNA製造市场正在快速发展。生物技术公司、学术机构以及合约开发与生产组织 (CDMO) 之间日益加强的合作正在加速创新并扩大市场准入。基因合成、酶促 DNA 生产和自动化技术的进步正在提高 DNA 製造流程的扩充性、速度和精确度。

由于其在基因治疗、mRNA 疫苗、诊断检测开发、细胞工程等各种应用中发挥关键作用，该市场正在获得发展动力。随着对高品质质体DNA 和 GMP 级材料的需求增加，新兴企业和传统供应商正在扩大其产能以满足全球需求。

酶合成、无细胞系统和连续生产领域的创新正在重塑传统工作流程，并缩短週转时间。这些进步推动了基于DNA的工具在肿瘤学、感染疾病和再生医学领域的广泛应用。

随着该领域的成熟，DNA製造市场将成为推动下一代生物治疗、诊断和精准医疗解决方案的核心。

DNA製造市场报告重点

  • 按类型划分，合成DNA在2024年占据了DNA製造市场的主导地位。这种主导地位归功于其灵活性、扩充性以及在合成生物学、基因组编辑、诊断和下一代疗法中日益增长的作用。酵素合成和自动化技术的进步显着缩短了製造时间和成本，使得快速、高保真地产生客製化DNA序列成为可能。随着製药、农业和工业生物技术领域对精准工程DNA的需求不断增长，合成DNA在创新和应用方面的表现持续超越传统方法。
  • 按等级划分，2024 年研发级 DNA 占据了 DNA 製造市场的主导地位。这种主导地位主要归功于研发级 DNA 在学术机构、生技新兴企业和早期药物开发的广泛应用。基因编辑、合成生物学和疫苗研究领域的创新加速，持续推动对用于实验和临床前试验的经济高效、高品质 DNA 的需求。研发级 DNA 的灵活性和快速的周转时间使其成为迭代测试、概念验证试验和技术开发的重要资源。
  • 从应用角度来看，细胞和基因治疗将在2024年占据DNA製造市场的主导地位，占据43.90%的市场占有率。这一领先地位得益于针对癌症、罕见遗传疾病和再生医学的基因治疗平台的快速发展。细胞和基因治疗产品线对用作载体、模板和原料的高纯度质体和合成DNA的需求旺盛，大大推动了生产需求。
  • 从最终用途来看，製药和生物技术公司在2024年占据了DNA製造市场的主导地位，占据了48.68%的市场占有率。基因治疗、疫苗生产和生技药品开发领域对DNA相关投入的需求激增，推动了这一主导地位。随着这些公司推进临床研发管线并将新型疗法推向市场，它们对高品质、可扩展的DNA製造的依赖也日益增长。 DNA技术在精准医疗、肿瘤学和罕见疾病治疗领域的日益普及，也进一步巩固了它们在该领域的领导地位。
  • 2025年5月，专注于核酸疗法的受託製造厂商(CDMO) VGXI, Inc. 宣布其位于德克萨斯州康罗市的工厂已成功通过美国食品药物管理局(FDA) 的检查。这一里程碑使 VGXI 的客户能够提交涉及质体DNA（基因疗法和 mRNA 疫苗的关键成分）临床试验的生技药品核准申请 (BLA)。 VGXI 的成就彰显了其在质体DNA 生产领域的领先地位，提供可扩展的高纯度生产能力。该公司是值得信赖的合作伙伴，致力于在全球范围内推动改变生命的医学研究和创新。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • DNA製造市场的分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章 DNA 製造市场：按类型分類的业务分析

  • 类型细分细分仪表板
  • 全球 DNA 製造市场：按类型进行差异分析
  • 2018 年至 2030 年全球 DNA 製造市场规模及趋势分析（按类型）
  • 质体DNA
  • 合成DNA

第五章 DNA 製造市场：依等级分類的业务分析

  • 等级细分仪表板
  • 全球 DNA 製造市场：依等级的差异分析
  • 全球 DNA 製造市场规模与趋势分析（按等级，2018-2030 年）
  • GMP级
  • 研发级

第六章 DNA 製造市场：按应用进行的业务分析

  • 应用程式细分仪表板
  • 全球 DNA 製造市场：按应用进行差异分析
  • 全球 DNA 製造市场规模与趋势分析（按应用，2018-2030 年）
  • 细胞和基因治疗
  • 疫苗
  • 寡核苷酸药物
  • 其他的

第 7 章 DNA 製造市场：按最终用途的业务分析

  • 最终用途细分仪表板
  • 全球 DNA 製造市场：按最终用途进行差异分析
  • 2018 年至 2030 年全球 DNA 製造市场规模及趋势分析（依最终用途）
  • 製药和生物技术公司
  • 学术研究所
  • 合约研究组织

第 8 章 DNA 製造市场：区域估计与趋势分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • Charles River Laboratories
    • VGXI, Inc.
    • Danaher（Aldevron）
    • Thermo Fisher Scientific
    • Lonza
    • GenScript
    • Catalent
    • Wuxi AppTec
    • Kaneka Corp.
    • Eurofins Genomics
Product Code: GVR-4-68040-608-4

DNA Manufacturing Market Growth & Trends:

The global DNA manufacturing market size is projected to reach USD 14.96 billion by 2030, growing at a CAGR of 18.10% from 2025 to 2030, according to a new report by Grand View Research, Inc. The DNA manufacturing market is rapidly evolving, driven by rising demand for synthetic biology applications, personalized therapeutics, and advanced vaccine development. Increasing collaboration between biotech firms, academic institutions, and contract development and manufacturing organizations (CDMOs) is accelerating innovation and expanding market access. Technological advancements in gene synthesis, enzymatic DNA production, and automation enhance DNA manufacturing processes' scalability, speed, and precision.

This market is gaining momentum due to its critical role in various applications, including gene therapy, mRNA vaccines, diagnostic assay development, and cell engineering. As the need for high-quality plasmid DNA and GMP-grade materials grows, startups and legacy providers are expanding their capabilities to meet global demand.

Innovations in enzymatic synthesis, cell-free systems, and continuous manufacturing are reshaping traditional workflows and enabling faster turnaround times. These advancements support the broader adoption of DNA-based tools in oncology, infectious diseases, and regenerative medicine.

As the field matures, the DNA manufacturing market is positioned to be central in advancing the next generation of biotherapeutics, diagnostics, and precision health solutions.

DNA Manufacturing Market Report Highlights:

  • Based on type, synthetic DNA dominated the DNA manufacturing market in 2024. This dominance is attributed to its flexibility, scalability, and expanding role in synthetic biology, genome editing, diagnostics, and next-generation therapeutics. Advances in enzymatic synthesis and automation have significantly reduced production time and costs, enabling the rapid, high-fidelity generation of custom DNA sequences. As demand grows for precision-engineered DNA across pharmaceutical, agricultural, and industrial biotech sectors, synthetic DNA continues to outpace traditional methods in innovation and adoption.
  • Based on grade, R&D-grade DNA dominated the DNA manufacturing market in 2024. This dominance is primarily due to the widespread use of research-grade DNA in academic institutions, biotech startups, and early-stage drug development. Innovation in gene editing, synthetic biology, and vaccine research accelerates, and demand for cost-effective, high-quality DNA for experimental and preclinical studies continues to rise. The flexibility and faster turnaround of R&D-grade DNA make it an essential resource in iterative testing, proof-of-concept studies, and technology development.
  • Based on application, cell and gene therapy dominated the DNA manufacturing market in 2024, accounting for 43.90% market share. This leadership is driven by the rapid advancement of gene-based therapeutic platforms targeting cancer, rare genetic disorders, and regenerative medicine. High demand for high-purity plasmid and synthetic DNA for use as vectors, templates, or raw material in cell and gene therapy pipelines has significantly increased production requirements.
  • Based on end use, pharmaceutical and biotechnology companies dominated the DNA manufacturing market in 2024, accounting for 48.68% market share. The surge in demand for DNA-based inputs across gene therapy, vaccine production, and biologics development drives this dominance. As these companies advance clinical pipelines and bring novel therapeutics to market, their reliance on high-quality, scalable DNA manufacturing continues to grow. The increasing adoption of DNA technologies in precision medicine, oncology, and rare disease treatment further reinforces this segment's leadership.
  • In May 2025, VGXI, Inc., a contract development and manufacturing organization (CDMO) specializing in nucleic acid-based therapeutics, announced the successful completion of a U.S. Food and Drug Administration (FDA) inspection at its Conroe, Texas facility. This milestone enables VGXI's client to submit a Biologics License Application (BLA) for clinical trials involving plasmid DNA, a critical component in gene therapies and mRNA vaccines. VGXI's achievement underscores its leadership in plasmid DNA manufacturing, offering scalable and high-purity production capabilities. The company has been a trusted partner in advancing life-changing medical research and innovation worldwide

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Grade Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. DNA Manufacturing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. DNA Manufacturing Market: Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global DNA Manufacturing Market Type Movement Analysis
  • 4.3. Global DNA Manufacturing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Plasmid DNA
    • 4.4.1. Global Plasmid DNA based Market, 2018 - 2030 (USD Million)
  • 4.5. Synthetic DNA
    • 4.5.1. Global Synthetic DNA Market, 2018 - 2030 (USD Million)
      • 4.5.1.1. Gene Synthesis
        • 4.5.1.1.1. Global Gene Synthesis Market, 2018 - 2030 (USD Million)
      • 4.5.1.2. Oligonucleotide Synthesis
        • 4.5.1.2.1. Global Oligonucleotide Synthesis Market, 2018 - 2030 (USD Million)

Chapter 5. DNA Manufacturing Market: Grade Business Analysis

  • 5.1. Grade Segment Dashboard
  • 5.2. Global DNA Manufacturing Market Grade Movement Analysis
  • 5.3. Global DNA Manufacturing Market Size & Trend Analysis, by Grade, 2018 to 2030 (USD Million)
  • 5.4. GMP Grade
    • 5.4.1. Global GMP Grade Market, 2018 - 2030 (USD Million)
  • 5.5. R&D Grade
    • 5.5.1. Global R&D Grade Market, 2018 - 2030 (USD Million)

Chapter 6. DNA Manufacturing Market: Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global DNA Manufacturing Market Application Movement Analysis
  • 6.3. Global DNA Manufacturing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Cell & Gene Therapy
    • 6.4.1. Global Cell & Gene Therapy Market, 2018 - 2030 (USD Million)
  • 6.5. Vaccines
    • 6.5.1. Global Vaccines Market, 2018 - 2030 (USD Million)
  • 6.6. Oligonucleotide-based Drugs
    • 6.6.1. Global Oligonucleotide-based Drugs Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 7. DNA Manufacturing Market: End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global DNA Manufacturing Market End Use Movement Analysis
  • 7.3. Global DNA Manufacturing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. Global Pharmaceutical and Biotechnology Companies Devices Market, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 7.6. Contract Research Organizations
    • 7.6.1. Global Contract Research Organizations Market, 2018 - 2030 (USD Million)

Chapter 8. Regional DNA Manufacturing Market: Region Estimates & Trend Analysis

  • 8.1. North America
    • 8.1.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.1.2. U.S.
      • 8.1.2.1. Key country dynamics
      • 8.1.2.2. Competitive scenario
      • 8.1.2.3. Regulatory Framework
      • 8.1.2.4. Target Disease Prevalence
      • 8.1.2.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.1.3. Canada
      • 8.1.3.1. Key country dynamics
      • 8.1.3.2. Competitive scenario
      • 8.1.3.3. Regulatory Framework
      • 8.1.3.4. Target Disease Prevalence
      • 8.1.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.1.4. Mexico
      • 8.1.4.1. Key country dynamics
      • 8.1.4.2. Competitive scenario
      • 8.1.4.3. Regulatory Framework
      • 8.1.4.4. Target Disease Prevalence
      • 8.1.4.5. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2. Europe
    • 8.2.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.2. UK
      • 8.2.2.1. Key country dynamics
      • 8.2.2.2. Competitive scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Target Disease Prevalence
      • 8.2.2.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.3. Germany
      • 8.2.3.1. Key country dynamics
      • 8.2.3.2. Competitive scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Target Disease Prevalence
      • 8.2.3.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.4. France
      • 8.2.4.1. Key country dynamics
      • 8.2.4.2. Competitive scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Target Disease Prevalence
      • 8.2.4.5. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.5. Italy
      • 8.2.5.1. Key country dynamics
      • 8.2.5.2. Competitive scenario
      • 8.2.5.3. Regulatory Framework
      • 8.2.5.4. Target Disease Prevalence
      • 8.2.5.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.6. Spain
      • 8.2.6.1. Key country dynamics
      • 8.2.6.2. Competitive scenario
      • 8.2.6.3. Regulatory Framework
      • 8.2.6.4. Target Disease Prevalence
      • 8.2.6.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.7. Norway
      • 8.2.7.1. Key country dynamics
      • 8.2.7.2. Competitive scenario
      • 8.2.7.3. Regulatory Framework
      • 8.2.7.4. Target Disease Prevalence
      • 8.2.7.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.8. Sweden
      • 8.2.8.1. Key country dynamics
      • 8.2.8.2. Competitive scenario
      • 8.2.8.3. Regulatory Framework
      • 8.2.8.4. Target Disease Prevalence
      • 8.2.8.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.2.9. Denmark
      • 8.2.9.1. Key country dynamics
      • 8.2.9.2. Competitive scenario
      • 8.2.9.3. Regulatory Framework
      • 8.2.9.4. Target Disease Prevalence
      • 8.2.9.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3. Asia Pacific
    • 8.3.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.2. Japan
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Target Disease Prevalence
      • 8.3.2.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.3. China
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.4. India
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.5. Thailand
      • 8.3.5.1. Key country dynamics
      • 8.3.5.2. Competitive scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Target Disease Prevalence
      • 8.3.5.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.6. South Korea
      • 8.3.6.1. Key country dynamics
      • 8.3.6.2. Competitive scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Target Disease Prevalence
      • 8.3.6.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.3.7. Australia
      • 8.3.7.1. Key country dynamics
      • 8.3.7.2. Competitive scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Target Disease Prevalence
      • 8.3.7.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.4. Latin America
    • 8.4.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.4.2. Brazil
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.4.3. Argentina
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5. Middle East & Africa
    • 8.5.1. Middle East & Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.5.2. South Africa
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.5.3. Saudi Arabia
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.5.4. UAE
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 8.5.5. Kuwait
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Target Disease Prevalence
      • 8.5.5.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Charles River Laboratories
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Service Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. VGXI, Inc.
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Service Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Danaher (Aldevron)
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Service Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Thermo Fisher Scientific
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Service Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Lonza
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Service Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. GenScript
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Service Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Catalent
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Service Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Wuxi AppTec
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Service Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Kaneka Corp.
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Service Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Eurofins Genomics
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Service Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 North America DNA manufacturing market estimates & forecasts
  • Table 2 North America DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 3 North America DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 4 North America DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 5 North America DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 8 U.S DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 12 Canada DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 14 Mexico DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 15 Mexico DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 16 Mexico DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 17 Mexico DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 18 Europe DNA manufacturing market estimates & forecasts
  • Table 19 Europe DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 20 Europe DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 21 Europe DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 24 UK DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 25 UK DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 26 UK DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 28 Germany DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 29 Germany DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 30 Germany DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 31 France DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 32 France DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 33 France DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 34 France DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 37 Spain DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 39 Italy DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 40 Italy DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 41 Italy DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 42 Italy DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 43 Denmark DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 44 Denmark DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 45 Denmark DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 46 Denmark DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 47 Sweden DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 48 Sweden DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 49 Sweden DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 50 Sweden DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 51 Norway DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 52 Norway DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 53 Norway DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 54 Norway DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific DNA manufacturing market estimates & forecasts
  • Table 56 Asia Pacific DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 60 China DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 61 China DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 62 China DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 63 China DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 64 Japan DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 65 Japan DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 66 Japan DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 67 Japan DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 68 India DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 69 India DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 70 India DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 71 India DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 72 South Korea DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 73 South Korea DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 74 South Korea DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 75 South Korea DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 76 Australia DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 77 Australia DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 78 Australia DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 79 Australia DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 80 Thailand DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 81 Thailand DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 82 Thailand DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 83 Thailand DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 84 Latin America DNA manufacturing market estimates & forecasts
  • Table 85 Latin America DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 86 Latin America DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 87 Latin America DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 88 Latin America DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 89 Brazil DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 90 Brazil DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 91 Brazil DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 92 Brazil DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 93 Argentina DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 94 Argentina DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 95 Argentina DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 96 Argentina DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 97 MEA DNA manufacturing market estimates & forecasts
  • Table 98 MEA DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 99 MEA DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 100 MEA DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 101 MEA DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 102 South Africa DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 103 South Africa DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 104 South Africa DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 105 South Africa DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 110 UAE DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 111 UAE DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 112 UAE DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 113 UAE DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 114 Kuwait DNA manufacturing market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 115 Kuwait DNA manufacturing market estimates & forecasts, by grade, 2018 - 2030 (USD Million)
  • Table 116 Kuwait DNA manufacturing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 117 Kuwait DNA manufacturing market estimates & forecasts, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market snapshot
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market trends & outlook
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 PESTLE Analysis
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Strategy framework
  • Fig. 13 DNA manufacturing market: Type outlook key takeaways
  • Fig. 14 DNA manufacturing market: Type movement analysis
  • Fig. 15 Plasmid DNA market, 2018 - 2030 (USD Million)
  • Fig. 16 Synthetic DNA market, 2018 - 2030 (USD Million)
  • Fig. 17 Gene synthesis market, 2018 - 2030 (USD Million)
  • Fig. 18 Oligonucleotide synthesis market, 2018 - 2030 (USD Million)
  • Fig. 19 DNA Manufacturing market: Grade outlook key takeaways
  • Fig. 20 DNA Manufacturing market: Grade movement analysis
  • Fig. 21 GMP grade market, 2018 - 2030 (USD Million)
  • Fig. 22 R&D grade market, 2018 - 2030 (USD Million)
  • Fig. 23 DNA manufacturing market: Application outlook key takeaways
  • Fig. 24 DNA manufacturing market: Application movement analysis
  • Fig. 25 Cell & gene therapy market, 2018 - 2030 (USD Million)
  • Fig. 26 Vaccines market, 2018 - 2030 (USD Million)
  • Fig. 27 Oligonucleotide-based drugs market, 2018 - 2030 (USD Million)
  • Fig. 28 Others market, 2018 - 2030 (USD Million)
  • Fig. 29 DNA Manufacturing market: End Use outlook key takeaways
  • Fig. 30 DNA Manufacturing market: End Use movement analysis
  • Fig. 31 Pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 32 Contract research organizations market, 2018 - 2030 (USD Million)
  • Fig. 33 Academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 34 DNA manufacturing market, by region, 2018 - 2030 (USD Million)
  • Fig. 35 North America DNA manufacturing market, by country, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe DNA manufacturing market, by country, 2018 - 2030 (USD Million)
  • Fig. 40 UK DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 42 France DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific DNA manufacturing market, by country, 2018 - 2030 (USD Million)
  • Fig. 49 Japan DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 50 China DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 51 India DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America DNA manufacturing market, by country, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East & Africa DNA manufacturing market, by country, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait DNA manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 63 Key companies profiled